Search

Misook Yu

Supervisory Patent Examiner (ID: 13848, Phone: (571)272-0839 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642, 1641
Total Applications
878
Issued Applications
268
Pending Applications
204
Abandoned Applications
408

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5348773 [patent_doc_number] => 20090004134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF AN ERP57 PROTEIN TO A CELLULAR MEMBRANE' [patent_app_type] => utility [patent_app_number] => 11/845065 [patent_app_country] => US [patent_app_date] => 2007-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 13400 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004134.pdf [firstpage_image] =>[orig_patent_app_number] => 11845065 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/845065
KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF AN ERP57 PROTEIN TO A CELLULAR MEMBRANE Aug 24, 2007 Abandoned
Array ( [id] => 4939587 [patent_doc_number] => 20080076906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Antagonists of neuropilin receptor function and use thereof' [patent_app_type] => utility [patent_app_number] => 11/893413 [patent_app_country] => US [patent_app_date] => 2007-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 17393 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076906.pdf [firstpage_image] =>[orig_patent_app_number] => 11893413 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/893413
Antagonists of neuropilin receptor function and use thereof Aug 15, 2007 Abandoned
Array ( [id] => 4570658 [patent_doc_number] => 07824678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Antibodies against cancer antigen TMEFF2 and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/837337 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16481 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/824/07824678.pdf [firstpage_image] =>[orig_patent_app_number] => 11837337 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/837337
Antibodies against cancer antigen TMEFF2 and uses thereof Aug 9, 2007 Issued
Array ( [id] => 4903977 [patent_doc_number] => 20080113390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Personalized assay for the identification of an effective therapy for cancer' [patent_app_type] => utility [patent_app_number] => 11/891315 [patent_app_country] => US [patent_app_date] => 2007-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2690 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113390.pdf [firstpage_image] =>[orig_patent_app_number] => 11891315 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/891315
Personalized assay for the identification of an effective therapy for cancer Aug 7, 2007 Abandoned
Array ( [id] => 4823002 [patent_doc_number] => 20080227701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'ANTIANGIOGENIC POLYPEPTIDES AND METHODS FOR INHIBITING ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 11/829778 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10690 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227701.pdf [firstpage_image] =>[orig_patent_app_number] => 11829778 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/829778
ANTIANGIOGENIC POLYPEPTIDES AND METHODS FOR INHIBITING ANGIOGENESIS Jul 26, 2007 Abandoned
Array ( [id] => 4669358 [patent_doc_number] => 20080044418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Tumor Antigens and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/782310 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 28607 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044418.pdf [firstpage_image] =>[orig_patent_app_number] => 11782310 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/782310
Tumor Antigens and Uses Thereof Jul 23, 2007 Abandoned
Array ( [id] => 4682784 [patent_doc_number] => 20080249010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Method Of Inducing Apoptosis In Lymphoid Cells' [patent_app_type] => utility [patent_app_number] => 11/761942 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8937 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249010.pdf [firstpage_image] =>[orig_patent_app_number] => 11761942 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/761942
Method Of Inducing Apoptosis In Lymphoid Cells Jun 11, 2007 Abandoned
Array ( [id] => 190923 [patent_doc_number] => 07642234 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-05 [patent_title] => 'Beta-2-glycoprotein 1 is an inhibitor of angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/810521 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 31297 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/642/07642234.pdf [firstpage_image] =>[orig_patent_app_number] => 11810521 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/810521
Beta-2-glycoprotein 1 is an inhibitor of angiogenesis Jun 4, 2007 Issued
Array ( [id] => 5354705 [patent_doc_number] => 20090186049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'METHOD OF TREATING MAGE POSITIVE CANCER' [patent_app_type] => utility [patent_app_number] => 12/301541 [patent_app_country] => US [patent_app_date] => 2007-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8485 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186049.pdf [firstpage_image] =>[orig_patent_app_number] => 12301541 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/301541
METHOD OF TREATING MAGE POSITIVE CANCER May 23, 2007 Abandoned
Array ( [id] => 5091687 [patent_doc_number] => 20070231326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Immunological Methods of Treating Cancer' [patent_app_type] => utility [patent_app_number] => 11/804182 [patent_app_country] => US [patent_app_date] => 2007-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21923 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231326.pdf [firstpage_image] =>[orig_patent_app_number] => 11804182 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/804182
Immunological Methods of Treating Cancer May 16, 2007 Abandoned
Array ( [id] => 5258737 [patent_doc_number] => 20070212369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Colon Specific Genes and Proteins' [patent_app_type] => utility [patent_app_number] => 11/748211 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16867 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212369.pdf [firstpage_image] =>[orig_patent_app_number] => 11748211 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/748211
Colon Specific Genes and Proteins May 13, 2007 Abandoned
Array ( [id] => 5348741 [patent_doc_number] => 20090004102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease' [patent_app_type] => utility [patent_app_number] => 11/801415 [patent_app_country] => US [patent_app_date] => 2007-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 49724 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004102.pdf [firstpage_image] =>[orig_patent_app_number] => 11801415 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/801415
HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease May 8, 2007 Abandoned
Array ( [id] => 5259107 [patent_doc_number] => 20070212739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Novel cancer-associated antigens and methods of their identification and use' [patent_app_type] => utility [patent_app_number] => 11/799584 [patent_app_country] => US [patent_app_date] => 2007-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14800 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212739.pdf [firstpage_image] =>[orig_patent_app_number] => 11799584 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/799584
Cancer-associated antigens and methods of their identification and use May 1, 2007 Issued
Array ( [id] => 5085824 [patent_doc_number] => 20070275875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Method for preventing colon cancer' [patent_app_type] => utility [patent_app_number] => 11/799578 [patent_app_country] => US [patent_app_date] => 2007-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6242 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275875.pdf [firstpage_image] =>[orig_patent_app_number] => 11799578 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/799578
Method for preventing colon cancer May 1, 2007 Abandoned
Array ( [id] => 4910435 [patent_doc_number] => 20080021202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'NOVEL APOPTOSIS PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/739267 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22708 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20080021202.pdf [firstpage_image] =>[orig_patent_app_number] => 11739267 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/739267
Apoptosis proteins Apr 23, 2007 Issued
Array ( [id] => 4797872 [patent_doc_number] => 20080009458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'COP1 molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/786399 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21933 [patent_no_of_claims] => 112 [patent_no_of_ind_claims] => 73 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009458.pdf [firstpage_image] =>[orig_patent_app_number] => 11786399 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/786399
COP1 molecules and uses thereof Apr 9, 2007 Issued
Array ( [id] => 4688135 [patent_doc_number] => 20080032316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'TUMOR ASSOCIATED ANTIGENS AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/697639 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14569 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20080032316.pdf [firstpage_image] =>[orig_patent_app_number] => 11697639 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/697639
TUMOR ASSOCIATED ANTIGENS AND METHODS OF USING THE SAME Apr 5, 2007 Abandoned
Array ( [id] => 4833338 [patent_doc_number] => 20080131885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Biomarkers for cancer treatment' [patent_app_type] => utility [patent_app_number] => 11/732362 [patent_app_country] => US [patent_app_date] => 2007-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 15355 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131885.pdf [firstpage_image] =>[orig_patent_app_number] => 11732362 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/732362
Biomarkers for cancer treatment Apr 1, 2007 Issued
Array ( [id] => 4977279 [patent_doc_number] => 20070218512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'METHODS RELATED TO MMP26 STATUS AS A DIAGNOSTIC AND PROGNOSTIC TOOL IN CANCER MANAGEMENT' [patent_app_type] => utility [patent_app_number] => 11/680396 [patent_app_country] => US [patent_app_date] => 2007-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19927 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218512.pdf [firstpage_image] =>[orig_patent_app_number] => 11680396 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/680396
METHODS RELATED TO MMP26 STATUS AS A DIAGNOSTIC AND PROGNOSTIC TOOL IN CANCER MANAGEMENT Feb 27, 2007 Abandoned
Array ( [id] => 173544 [patent_doc_number] => 07658923 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26' [patent_app_type] => utility [patent_app_number] => 11/676164 [patent_app_country] => US [patent_app_date] => 2007-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 31336 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/658/07658923.pdf [firstpage_image] =>[orig_patent_app_number] => 11676164 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/676164
Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 Feb 15, 2007 Issued
Menu